IRD — Opus Genetics, Inc. stock price, charts and financials

QT67Opus Genetics, Inc.

Opus Genetics, Inc. (NASDAQ: IRD) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
5.18
-0.10-1.89%
OverviewShort InterestFilings
IRDQT67Opus Genetics, Inc.·NASDAQ
5.18-1.89%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 11, 20268-KCurrent report
Sep 11, 20264Statement of changes in beneficial ownership
Sep 09, 20268-KCurrent report
Sep 08, 20264Statement of changes in beneficial ownership
Sep 08, 20264Statement of changes in beneficial ownership
Aug 14, 2026EFFECTNotice of effectiveness
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 07, 2026S-3Shelf registration statement
Aug 06, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Jul 27, 20264Statement of changes in beneficial ownership
Jul 27, 20264Statement of changes in beneficial ownership
Jul 27, 20264Statement of changes in beneficial ownership
Jul 27, 20264Statement of changes in beneficial ownership
Jun 17, 2026424B2Prospectus
Jun 16, 20268-KCurrent report
Jun 16, 20268-KCurrent report
Jun 15, 2026EFFECTNotice of effectiveness
Jun 05, 2026S-3Shelf registration statement
May 20, 2026SC 13D/ABeneficial ownership statement (active, amended)
May 20, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
#1 / 25 of 366
Page
▼
/ 15